SpringerLink
Log in

Contribution of hypoxia to Alzheimer’s disease: is HIF-1α a mediator of neurodegeneration?

  • Multi-author Review
  • Published:
Cellular and Molecular Life Sciences Aims and scope Submit manuscript

Abstract

The mammalian brain is extremely sensitive to alterations in cellular homeostasis as a result of environmental or physiological insults. In particular, hypoxic/ischemic challenges (i.e. reduced oxygen and/or glucose delivery) cause severe and detrimental alterations in brain function and can trigger neuronal cell death within minutes. Unfortunately, as we age, oxygen delivery to cells and tissues is impaired, thereby increasing the susceptibility of neurons to damage. Thus, hypoxic (neuronal) adaptation is significantly compromised during aging. Many neurological diseases, such as stroke, Alzheimer’s disease (AD), Parkinson’s disease and diabetes, are characterized by hypoxia, a state that is believed to only exacerbate disease progression. However, the contribution of hypoxia and hypoxia-mediated pathways to neurodegeneration remains unclear. This review discusses current evidence on the contribution of oxygen deprivation to AD, with an emphasis on hypoxia inducible transcription factor-1 (HIF-1)-mediated pathways and the association of AD with the cytoskeleton regulator cyclin-dependent kinase 5. (Part of a multi-author review.)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Siesjo BK (1988) Mechanisms of ischemic brain damage. Crit Care Med 16:954–963

    Article  CAS  PubMed  Google Scholar 

  2. Yager JY, Wright S, Armstrong EA, Jahraus CM, Saucier DM (2006) The influence of aging on recovery following ischemic brain damage. Behav Brain Res 173:171–180

    Article  PubMed  Google Scholar 

  3. Kolb B (2003) Overview of cortical plasticity and recovery from brain injury. Phys Med Rehabil Clin N Am 14:S7–S25

    Google Scholar 

  4. Marini AM, Choi J, Labutta R (2001) Synaptic deprivation and age-related vulnerability to hypoxic–ischemic neuronal injury. A hypothesis. Ann N Y Acad Sci 939:238–253

    CAS  PubMed  Google Scholar 

  5. Jellinger KA, Attems J (2005) Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. J Neurol Sci 229–230:37–41

    Article  PubMed  Google Scholar 

  6. Joseph J, Shukitt-Hale B, Denisova NA, Martin A, Perry G, Smith MA (2001) Copernicus revisited: amyloid beta in Alzheimer’s disease. Neurobiol Aging 22:131–146

    Article  CAS  PubMed  Google Scholar 

  7. Tamaoka A, Sawamura N, Fukushima T, Shoji S, Matsubara E, Shoji M, Hirai S, Furiya Y, Endoh R, Mori H (1997) Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer’s disease. J Neurol Sci 148:41–45

    Article  CAS  PubMed  Google Scholar 

  8. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB et al (1992) Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359:322–325

    Article  CAS  PubMed  Google Scholar 

  9. Steinhilb ML, Dias-Santagata D, Mulkearns EE, Shulman JM, Biernat J, Mandelkow EM, Feany MB (2007) S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila. J Neurosci Res 85:1271–1278

    Article  CAS  PubMed  Google Scholar 

  10. Baumann K, Mandelkow EM, Biernat J, Piwnica-Worms H, Mandelkow E (1993) Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett 336:417–424

    Article  CAS  PubMed  Google Scholar 

  11. Galloway PG, Perry G, Gambetti P (1987) Hirano body filaments contain actin and actin-associated proteins. J Neuropathol Exp Neurol 46:185–199

    Article  CAS  PubMed  Google Scholar 

  12. Hirano A (1994) Hirano bodies and related neuronal inclusions. Neuropathol Appl Neurobiol 20:3–11

    Article  CAS  PubMed  Google Scholar 

  13. Anderton BH (2002) Ageing of the brain. Mech Ageing Dev 123:811–817

    Article  CAS  PubMed  Google Scholar 

  14. Mitake S, Ojika K, Hirano A (1997) Hirano bodies and Alzheimer’s disease. Kaohsiung J Med Sci 13:10–18

    CAS  PubMed  Google Scholar 

  15. Minamide LS, Striegl AM, Boyle JA, Meberg PJ, Bamburg JR (2000) Neurodegenerative stimuli induce persistent ADF/cofilin–actin rods that disrupt distal neurite function. Nat Cell Biol 2:628–636

    Article  CAS  PubMed  Google Scholar 

  16. Coppede F, Mancuso M, Siciliano G, Migliore L, Murri L (2006) Genes and the environment in neurodegeneration. Biosci Rep 26:341–367

    Article  CAS  PubMed  Google Scholar 

  17. Aliev G, Seyidova D, Neal ML, Shi J, Lamb BT, Siedlak SL, Vinters HV, Head E, Perry G, Lamanna JC, Friedland RP, Cotman CW (2002) Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Ann N Y Acad Sci 977:45–64

    Article  CAS  PubMed  Google Scholar 

  18. Baldi I, Lebailly P, Mohammed-Brahim B, Letenneur L, Dartigues JF, Brochard P (2003) Neurodegenerative diseases and exposure to pesticides in the elderly. Am J Epidemiol 157:409–414

    Article  PubMed  Google Scholar 

  19. Mattson MP (1997) Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 77:1081–1132

    CAS  PubMed  Google Scholar 

  20. Desmond DW, Moroney JT, Sano M, Stern Y (2002) Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 33:2254–2260

    Article  PubMed  Google Scholar 

  21. Kalaria RN (2000) The role of cerebral ischemia in Alzheimer’s disease. Neurobiol Aging 21:321–330

    Article  CAS  PubMed  Google Scholar 

  22. Egashira N, Iwasaki K, Ishibashi M, Hatip-Al-Khatib I, Wolozin B, Mishima K, Irie K, Fujiwara M (2002) Hypoxia enhances beta-amyloid-induced apoptosis in rat cultured hippocampal neurons. Jpn J Pharmacol 90:321–327

    Article  CAS  PubMed  Google Scholar 

  23. Sun X, He G, Qing H, Zhou W, Dobie F, Cai F, Staufenbiel M, Huang LE, Song W (2006) Hypoxia facilitates Alzheimer’s disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci USA 103:18727–18732

    Article  CAS  PubMed  Google Scholar 

  24. Chen GJ, Xu J, Lahousse SA, Caggiano NL, de la Monte SM (2003) Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: potential strategies for neuroprotection. J Alzheimers Dis 5:209–228

    PubMed  Google Scholar 

  25. Jendroska K, Hoffmann OM, Patt S (1997) Amyloid beta peptide and precursor protein (APP) in mild and severe brain ischemia. Ann N Y Acad Sci 826:401–405

    Article  CAS  PubMed  Google Scholar 

  26. Shi J, Yang SH, Stubley L, Day AL, Simpkins JW (2000) Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res 853:1–4

    Article  CAS  PubMed  Google Scholar 

  27. Hall ED, Oostveen JA, Dunn E, Carter DB (1995) Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils. Exp Neurol 135:17–27

    Article  CAS  PubMed  Google Scholar 

  28. LaFerla FM (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer’s disease. Nat Rev Neurosci 3:862–872

    Article  CAS  PubMed  Google Scholar 

  29. Pearson HA, Peers C (2006) Physiological roles for amyloid beta peptides. J Physiol 575:5–10

    Article  CAS  PubMed  Google Scholar 

  30. Webster NJ, Ramsden M, Boyle JP, Pearson HA, Peers C (2006) Amyloid peptides mediate hypoxic increase of L-type Ca2+ channels in central neurones. Neurobiol Aging 27:439–445

    Article  CAS  PubMed  Google Scholar 

  31. Scragg JL, Fearon IM, Boyle JP, Ball SG, Varadi G, Peers C (2005) Alzheimer’s amyloid peptides mediate hypoxic up-regulation of L-type Ca2+ channels. FASEB J 19:150–152

    CAS  PubMed  Google Scholar 

  32. Bazan NG, Lukiw WJ (2002) Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells. J Biol Chem 277:30359–30367

    Article  CAS  PubMed  Google Scholar 

  33. Wenger RH, Gassmann M (1997) Oxygen(es) and the hypoxia-inducible factor-1. Biol Chem 378:609–616

    CAS  PubMed  Google Scholar 

  34. Wang GL, Semenza GL (1993) General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 90:4304–4308

    Article  CAS  PubMed  Google Scholar 

  35. Soucek T, Cumming R, Dargusch R, Maher P, Schubert D (2003) The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39:43–56

    Article  CAS  PubMed  Google Scholar 

  36. Semenza GL (1998) Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev 8:588–594

    Article  CAS  PubMed  Google Scholar 

  37. Ratcliffe PJ, O’Rourke JF, Maxwell PH, Pugh CW (1998) Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J Exp Biol 201:1153–1162

    CAS  PubMed  Google Scholar 

  38. Hofer T, Wenger H, Gassmann M (2002) Oxygen sensing, HIF-1alpha stabilization and potential therapeutic strategies. Pflugers Arch 443:503–507

    Article  CAS  PubMed  Google Scholar 

  39. Acker T, Acker H (2004) Cellular oxygen sensing need in CNS function: physiological and pathological implications. J Exp Biol 207:3171–3188

    Article  CAS  PubMed  Google Scholar 

  40. Maxwell PH, Ratcliffe PJ (2002) Oxygen sensors and angiogenesis. Semin Cell Dev Biol 13:29–37

    Article  CAS  PubMed  Google Scholar 

  41. Semenza GL (2001) HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107:1–3

    Article  CAS  PubMed  Google Scholar 

  42. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG Jr (2001) HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292:464–468

    Article  CAS  PubMed  Google Scholar 

  43. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ (2001) Targeting of HIF-alpha to the von Hippel–Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468–472

    Article  CAS  PubMed  Google Scholar 

  44. Schubert D, Chevion M (1995) The role of iron in beta amyloid toxicity. Biochem Biophys Res Commun 216:702–707

    Article  CAS  PubMed  Google Scholar 

  45. Crapper McLachlan DR, Dalton AJ, Kruck TP, Bell MY, Smith WL, Kalow W, Andrews DF (1991) Intramuscular desferrioxamine in patients with Alzheimer’s disease. Lancet 337:1304–1308

    Article  CAS  PubMed  Google Scholar 

  46. Vangeison G, Carr D, Federoff HJ, Rempe DA (2008) The good, the bad, and the cell type-specific roles of hypoxia inducible factor-1 alpha in neurons and astrocytes. J Neurosci 28:1988–1993

    Article  CAS  PubMed  Google Scholar 

  47. Chavez JC, LaManna JC (2003) Hypoxia-inducible factor-1alpha accumulation in the rat brain in response to hypoxia and ischemia is attenuated during aging. Adv Exp Med Biol 510:337–341

    CAS  PubMed  Google Scholar 

  48. Liu Y, Liu F, Iqbal K, Grundke-Iqbal I, Gong CX (2008) Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Lett 582:359–364

    Article  CAS  PubMed  Google Scholar 

  49. Chong ZZ, Li F, Maiese K (2005) Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity. Curr Neurovasc Res 2:387–399

    Article  CAS  PubMed  Google Scholar 

  50. Brettschneider J, Widl K, Ehrenreich H, Riepe M, Tumani H (2006) Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases. Neurosci Lett 404:347–351

    Article  CAS  PubMed  Google Scholar 

  51. Storkebaum E, Lambrechts D, Carmeliet P (2004) VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26:943–954

    Article  CAS  PubMed  Google Scholar 

  52. Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Oh H, Van Damme P, Rutten B, Man WY, De Mol M, Wyns S, Manka D, Vermeulen K, Van Den Bosch L, Mertens N, Schmitz C, Robberecht W, Conway EM, Collen D, Moons L, Carmeliet P (2005) Treatment of motor neuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci 8:85–92

    Article  CAS  PubMed  Google Scholar 

  53. Del Bo R, Scarlato M, Ghezzi S, Martinelli Boneschi F, Fenoglio C, Galbiati S, Virgilio R, Galimberti D, Galimberti G, Crimi M, Ferrarese C, Scarpini E, Bresolin N, Comi GP (2005) Vascular endothelial growth factor gene variability is associated with increased risk for AD. Ann Neurol 57:373–380

    Article  CAS  PubMed  Google Scholar 

  54. Mateo I, Llorca J, Infante J, Rodriguez-Rodriguez E, Sanchez-Quintana C, Sanchez-Juan P, Berciano J, Combarros O (2006) Case–control study of vascular endothelial growth factor (VEGF) genetic variability in Alzheimer’s disease. Neurosci Lett 401:171–173

    Article  CAS  PubMed  Google Scholar 

  55. Chapuis J, Tian J, Shi J, Bensemain F, Cottel D, Lendon C, Amouyel P, Mann D, Lambert JC (2006) Association study of the vascular endothelial growth factor gene with the risk of develo** Alzheimer’s disease. Neurobiol Aging 27:1212–1215

    Article  CAS  PubMed  Google Scholar 

  56. Malyshev IY, Wiegant FA, Mashina SY, Torshin VI, Goryacheva AV, Khomenko IP, Kruglov SV, Pokidyshev DA, Popkova EV, Pshennikova MG, Vlasova MA, Zelenina OM, Manukhina EB (2005) Possible use of adaptation to hypoxia in Alzheimer’s disease: a hypothesis. Med Sci Monit 11:HY31–HY38

    CAS  PubMed  Google Scholar 

  57. Zhang X, Zhou K, Wang R, Cui J, Lipton SA, Liao FF, Xu H, Zhang YW (2007) Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J Biol Chem 282:10873–10880

    Article  CAS  PubMed  Google Scholar 

  58. Wang R, Zhang YW, Zhang X, Liu R, Zhang X, Hong S, **a K, **a J, Zhang Z, Xu H (2006) Transcriptional regulation of APH-1A and increased gamma-secretase cleavage of APP and Notch by HIF-1 and hypoxia. FASEB J 20:1275–1277

    Article  PubMed  CAS  Google Scholar 

  59. Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, Wong PC (2001) BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci 4:233–234

    Article  CAS  PubMed  Google Scholar 

  60. Ohno M, Sametsky EA, Younkin LH, Oakley H, Younkin SG, Citron M, Vassar R, Disterhoft JF (2004) BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer’s disease. Neuron 41:27–33

    Article  CAS  PubMed  Google Scholar 

  61. Cui JG, Fraser PE, St George-Hyslop P, Westaway D, Lukiw WJ (2004) Potential roles for presenilin-1 in oxygen sensing and in glial-specific gene expression. Neuroreport 15:2025–2028

    Article  CAS  PubMed  Google Scholar 

  62. Zhang S, Zhang Z, Sandhu G, Ma X, Yang X, Geiger JD, Kong J (2007) Evidence of oxidative stress-induced BNIP3 expression in amyloid beta neurotoxicity. Brain Res 1138:221–230

    Article  CAS  PubMed  Google Scholar 

  63. Mendoza-Naranjo A, Gonzalez-Billault C, Maccioni RB (2007) Abeta1–42 stimulates actin polymerization in hippocampal neurons through Rac1 and Cdc42 Rho GTPases. J Cell Sci 120:279–288

    Article  CAS  PubMed  Google Scholar 

  64. Lippa CF, Hamos JE, Pulaski-Salo D, DeGennaro LJ, Drachman DA (1992) Alzheimer’s disease and aging: effects on perforant pathway perikarya and synapses. Neurobiol Aging 13:405–411

    Article  CAS  PubMed  Google Scholar 

  65. Friedman JE, Chow EJ, Haddad GG (1998) State of actin filaments is changed by anoxia in cultured rat neocortical neurons. Neuroscience 82:421–427

    Article  CAS  PubMed  Google Scholar 

  66. de la Monte SM, Neely TR, Cannon J, Wands JR (2000) Oxidative stress and hypoxia-like injury cause Alzheimer-type molecular abnormalities in central nervous system neurons. Cell Mol Life Sci 57:1471–1481

    Article  Google Scholar 

  67. McGough A, Pope B, Chiu W, Weeds A (1997) Cofilin changes the twist of F-actin: implications for actin filament dynamics and cellular function. J Cell Biol 138:771–781

    Article  CAS  PubMed  Google Scholar 

  68. Maloney MT, Bamburg JR (2007) Cofilin-mediated neurodegeneration in Alzheimer’s disease and other amyloidopathies. Mol Neurobiol 35:21–44

    Article  CAS  PubMed  Google Scholar 

  69. Liu R, Pei JJ, Wang XC, Zhou XW, Tian Q, Winblad B, Wang JZ (2005) Acute anoxia induces tau dephosphorylation in rat brain slices and its possible underlying mechanisms. J Neurochem 94:1225–1234

    Article  CAS  PubMed  Google Scholar 

  70. Stys PK, Jiang Q (2002) Calpain-dependent neurofilament breakdown in anoxic and ischemic rat central axons. Neurosci Lett 328:150–154

    Article  CAS  PubMed  Google Scholar 

  71. Magin TM, Reichelt J, Hatzfeld M (2004) Emerging functions: diseases and animal models reshape our view of the cytoskeleton. Exp Cell Res 301:91–102

    Article  CAS  PubMed  Google Scholar 

  72. Ishiguro K, Shiratsuchi A, Sato S, Omori A, Arioka M, Kobayashi S, Uchida T, Imahori K (1993) Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett 325:167–172

    Article  CAS  PubMed  Google Scholar 

  73. Hosoi T, Uchiyama M, Okumura E, Saito T, Ishiguro K, Uchida T, Okuyama A, Kishimoto T, Hisanaga S (1995) Evidence for cdk5 as a major activity phosphorylating tau protein in porcine brain extract. J Biochem 117:741–749

    CAS  PubMed  Google Scholar 

  74. Cheung ZH, Ip NY (2004) Cdk5: mediator of neuronal death and survival. Neurosci Lett 361:47–51

    Article  CAS  PubMed  Google Scholar 

  75. Dhavan R, Tsai LH (2001) A decade of CDK5. Nat Rev Mol Cell Biol 2:749–759

    Article  CAS  PubMed  Google Scholar 

  76. Liu X, Van Vleet T, Schnellmann RG (2004) The role of calpain in oncotic cell death. Annu Rev Pharmacol Toxicol 44:349–370

    Article  CAS  PubMed  Google Scholar 

  77. Ahlijanian MK, Barrezueta NX, Williams RD, Jakowski A, Kowsz KP, McCarthy S, Coskran T, Carlo A, Seymour PA, Burkhardt JE, Nelson RB, McNeish JD (2000) Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc Natl Acad Sci USA 97:2910–2915

    Article  CAS  PubMed  Google Scholar 

  78. Pei JJ, Grundke-Iqbal I, Iqbal K, Bogdanovic N, Winblad B, Cowburn RF (1998) Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer’s disease neurofibrillary degeneration. Brain Res 797:267–277

    Article  CAS  PubMed  Google Scholar 

  79. Van den Haute C, Spittaels K, Van Dorpe J, Lasrado R, Vandezande K, Laenen I, Geerts H, Van Leuven F (2001) Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice. Neurobiol Dis 8:32–44

    Article  PubMed  CAS  Google Scholar 

  80. Li BS, Zhang L, Takahashi S, Ma W, Jaffe H, Kulkarni AB, Pant HC (2002) Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J 21:324–333

    Article  CAS  PubMed  Google Scholar 

  81. O’Hare MJ, Kushwaha N, Zhang Y, Aleyasin H, Callaghan SM, Slack RS, Albert PR, Vincent I, Park DS (2005) Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excitotoxic neuronal death. J Neurosci 25:8954–8966

    Article  PubMed  CAS  Google Scholar 

  82. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405:360–364

    Article  CAS  PubMed  Google Scholar 

  83. Ma E, Haddad G (1999) A Drosophila CDK5alpha-like molecule and its possible role in response to O(2) deprivation. Biochem Biophys Res Commun 261:459–463

    Article  CAS  PubMed  Google Scholar 

  84. Hayashi T, Warita H, Abe K, Itoyama Y (1999) Expression of cyclin-dependent kinase 5 and its activator p35 in rat brain after middle cerebral artery occlusion. Neurosci Lett 265:37–40

    Article  CAS  PubMed  Google Scholar 

  85. Mitsios N, Pennucci R, Krupinski J, Sanfeliu C, Gaffney J, Kumar P, Kumar S, Juan-Babot O, Slevin M (2007) Expression of cyclin-dependent kinase 5 mRNA and protein in the human brain following acute ischemic stroke. Brain Pathol 17:11–23

    Article  CAS  PubMed  Google Scholar 

  86. Rashidian J, Iyirhiaro G, Aleyasin H, Rios M, Vincent I, Callaghan S, Bland RJ, Slack RS, During MJ, Park DS (2005) Multiple cyclin-dependent kinases signals are critical mediators of ischemia/hypoxic neuronal death in vitro and in vivo. Proc Natl Acad Sci USA 102:14080–14085

    Article  CAS  PubMed  Google Scholar 

  87. Strocchi P, Pession A, Dozza B (2003) Up-regulation of cDK5/p35 by oxidative stress in human neuroblastoma IMR-32 cells. J Cell Biochem 88:758–765

    Article  CAS  PubMed  Google Scholar 

  88. Wu DC, Yu YP, Lee NT, Yu AC, Wang JH, Han YF (2000) The expression of Cdk5, p35, p39, and Cdk5 kinase activity in develo**, adult, and aged rat brains. Neurochem Res 25:923–929

    Article  CAS  PubMed  Google Scholar 

  89. Tamada Y, Nakajima E, Nakajima T, Shearer TR, Azuma M (2005) Proteolysis of neuronal cytoskeletal proteins by calpain contributes to rat retinal cell death induced by hypoxia. Brain Res 1050:148–155

    Article  CAS  PubMed  Google Scholar 

  90. Vartiainen N, Keksa-Goldsteine V, Goldsteins G, Koistinaho J (2002) Aspirin provides cyclin-dependent kinase 5-dependent protection against subsequent hypoxia/reoxygenation damage in culture. J Neurochem 82:329–335

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Veterinary Physiology and Zurich Centre for Integrative Human Physiology (ZIHP), University of Zurich, Zurich, Switzerland

    O. O. Ogunshola & X. Antoniou

  2. Institute of Veterinary Physiology, Vetsuisse Faculty of the University of Zurich, Winterthurerstrasse 260, 8057, Zurich, Switzerland

    O. O. Ogunshola & X. Antoniou

Authors
  1. O. O. Ogunshola
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. X. Antoniou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O. O. Ogunshola.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ogunshola, O.O., Antoniou, X. Contribution of hypoxia to Alzheimer’s disease: is HIF-1α a mediator of neurodegeneration?. Cell. Mol. Life Sci. 66, 3555–3563 (2009). https://doi.org/10.1007/s00018-009-0141-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-009-0141-0

Keywords

Search

Navigation